MedPath

COVISHIELD

COVISHIELD

Authorization By Interim Order Expired
DIN Number

02512947

Drug Class

Human

Market Date

Mar 3, 2021

Company
HC

Verity Pharmaceuticals Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02512947
AIG Number0162722001
Classification & Schedule
C
Drug Class
Human
S
Schedule
COVID-19 - IO - Authorization ,  Schedule D
A
ATC Code
J07BN02 COVID-19, VIRAL VECTOR, NON-REPLICATING
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
Health Canada Classification

ACTIVE INGREDIENTS (1)

CHADOX1-S [RECOMBINANT]Active
Strength: 50000000000 VP / 0.5 ML
Monograph: CHADOX1-S [RECOMBINANT]

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.